Jublin-M Capsule

By Jublin-M

Rx

10 Capsule in a Strip

Composition icon

Composition

Methylcobalamin(750mcg) + Pregabalin(75mg)

Manufacturer - Dr. Johns Laboratories Pvt Ltd icon

Manufacturer - Dr. Johns Laboratories Pvt Ltd

212, Choudhary Dilip Singh Bhawan, Shahpur Jat, New Delhi, India , Pin Code - 110049

Expires on or after icon

Expires on or after

October, 2025

About Jublin-M Capsule

JUBLIN M CAPSULE is a prescribed medication used to manage neuropathic pain caused by damaged nerves. This type of pain stems from nerve damage or dysfunction in the nervous system, leading to sensations like tingling, burning, or stabbing. It falls under the category of anticonvulsants, which are meant to alleviate neuropathic pain. The capsule contains two active ingredients: Mecobalamin (vitamin B12) and Pregabalin. Mecobalamin aids in protecting nerve fibers and revitalizing nerve cells by producing myelin, while Pregabalin alters the transmission of messages between nerves and the brain, collectively providing relief from nerve-related pain.

Patients should take JUBLIN M CAPSULE precisely as directed by their healthcare provider. The duration of treatment is determined by the doctor based on the individual's medical condition. Some individuals may encounter common side effects like nausea, dizziness, stomach discomfort, dry mouth, and drowsiness. Fortunately, these side effects are typically mild and tend to improve over time. However, if these effects persist or worsen, consulting with a healthcare professional is recommended. It is crucial to avoid consuming JUBLIN M CAPSULE if pregnant or breastfeeding unless advised by a doctor due to potential risks.

Furthermore, individuals taking JUBLIN M CAPSULE should exercise caution when driving or engaging in tasks that require alertness due to potential drowsiness and dizziness associated with the medication. This drug is not recommended for use in children due to limited information on its safety and efficacy in this age group. Avoiding alcohol while on JUBLIN M CAPSULE is advisable, as it can exacerbate dizziness and drowsiness. Informing your healthcare provider about existing health conditions, such as heart disease, severe kidney issues, stomach disorders, or diabetes, is important before starting this medication to prevent unwanted side effects.


Benefits

Jublin-M Capsule and Jublin-M Capsule offer multiple benefits for those suffering from neuropathic pain. These medications are specially designed to alleviate chronic pain resulting from nerve damage caused by diabetes, shingles, spinal cord injury, and other conditions. By effectively reducing pain signals traveling through damaged nerves and to the brain, these capsules help in managing pain and its related symptoms. Moreover, the combination of active ingredients in Jublin-M Capsule and Jublin-M Capsule, such as Pregabalin, Alpha-lipoic acid, folic acid, methylcobalamin, and pyridoxine hydrochloride, not only reduce pain but also improve nerve conduction, rejuvenate damaged nerve cells, and protect nerve tissues and brain.


Regular intake of these capsules can lead to a significant improvement in physical and social functioning, overall quality of life, and relief from neuropathic pain conditions like diabetic neuropathy, drug-induced neuropathy, alcoholic neuropathy, trigeminal neuralgia, fibromyalgia, and post-herpetic neuralgia. The antioxidant properties of Alpha-lipoic acid, the essential nutrients provided by folic acid, the production of myelin by Methylcobalamin, and the facilitation of myelin and neurotransmitter synthesis by pyridoxine hydrochloride work synergistically to address the root causes of neuropathic pain and its associated symptoms. In summary, Jublin-M Capsule and Jublin-M Capsuleoffer a comprehensive approach to managing neuropathic pain, improving overall health, and enhancing the quality of life for individuals suffering from nerve damage-related conditions.


How to use the Jublin-M Capsule

To use Jublin-M Capsule properly, follow the instructions given by your doctor. You can take this capsule with or without food, but it's best to take it at the same time every day. Swallow the capsule whole with a glass of water - do not chew or break it.


For Jublin-M Capsule, take it as a whole with a glass of water, and do not chew or break it.


When taking Jublin-M Capsule, follow your physician's advice. Swallow the capsule with a glass of water and do not crush or chew it. Your doctor will determine the right dose and duration for you based on factors like your age, weight, and the condition being treated. Do not stop taking Jublin-M Capsule unless your doctor tells you to do so.


Remember, always consult your healthcare provider for personalized instructions on how to use Jublin-M Capsule effectively.


Uses of Jublin-M Capsule

Jublin-M Capsule is commonly used for the treatment of neuropathic pain. Specifically, it is effective in managing painful diabetic neuropathy in adult patients. This medication helps alleviate the discomfort and sensitivity associated with this form of neuropathic pain. By targeting the underlying causes of neuropathic pain, Jublin-M Capsule can provide relief and improve the quality of life for individuals suffering from this condition. It is an important option for those looking for an effective treatment to manage their neuropathic pain symptoms.


What conditions Jublin-M Capsule treats?

Neuropathic pain is caused by damage to sensory nerves. This type of pain is associated with chronic progressive nerve diseases, infections, or injuries. Symptoms of neuropathic pain may include intermittent or continuous prickling, stabbing, tingling, or burning sensations. Patients may also experience numbness and loss of sensations. Unlike regular injury-related pain signals, neuropathic pain occurs without any specific trigger, leading to spontaneous and unprovoked pain sensations. Other symptoms may include difficulty resting or sleeping, as well as pain evoked by non-painful events.


Should you consult a doctor?

If you experience any discomfort or adverse reactions while taking Jublin-M Capsule, it is important to seek medical advice promptly. Contact your doctor if you have diabetes and notice any unusual changes in your blood sugar levels. It is also advisable to consult your healthcare provider if you are prone to constipation and experience worsening symptoms. For individuals with a history of drug abuse or dependence, seeking medical help is crucial if there are any concerning developments during treatment with this medication. Additionally, if you have nervous system disorders or a folate-dependent tumor, it is recommended to reach out to your doctor if there are any unexpected changes or complications while taking Jublin-M Capsule. Always prioritize your health and well-being by consulting a healthcare professional if you have any concerns.


Side effects of Jublin-M Capsule

Side Effects:


When taking Jublin-M Capsule, you may experience some side effects as your body adjusts to the medicine. These side effects are usually minor and may go away on their own without medical intervention. Common side effects include dizziness, sleepiness, tiredness, and uncoordinated body movements. Headache, nausea, vomiting, and heartburn are also reported side effects.


Some less common side effects may occur, such as changes in appetite and weight, low or high blood sugar levels, and alterations in mood and perception. You may also experience visual disturbances, mental impairment, sexual problems, changes in eyesight, skin sensitivity, and taste alterations. Other potential side effects include heart rhythm changes, flushing, nasal congestion, increased salivation, sweating, muscle pain, troubled urination, weakness, chest tightness, and elevated blood pressure.


In rare cases, more severe side effects may occur, such as allergic reactions characterized by swelling, hives, or difficulty breathing. It is important to stop taking the capsule and seek immediate medical attention if you experience symptoms like swollen face, skin blistering, vision changes, kidney issues, or suicidal thoughts. Other serious side effects that require immediate medical attention include fits, shallow breathing, and jaundice.


If you notice any of these side effects while taking Jublin-M Capsule, it is advisable to consult your doctor promptly to ensure appropriate management and monitoring.


Safety advice

scroll

liver

Jublin-M Capsule is considered safe for individuals with liver disease. Based on the limited available data, it appears that adjusting the dose of Jublin-M Capsule may not be necessary for these patients. However, if you have liver impairment, it is recommended to consult your doctor before using this medication. Dose adjustment may be required for individuals with liver issues, so it is important to seek advice from your physician if you have concerns about your liver health.

scroll

kidney

When taking Jublin-M Capsule, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so consulting your doctor is important, especially if you have kidney impairment or concerns about it.

scroll

alcohol

Avoid drinking alcohol while taking Jublin-M Capsule as it may increase drowsiness.

scroll

driving

Take caution when driving while using Jublin-M Capsule, as it may decrease alertness, affect vision, and cause drowsiness or dizziness. Avoid driving if experiencing these symptoms. Jublin-M Capsule does not impact driving ability.

scroll

pregnancy

Jublin-M Capsule may be unsafe during pregnancy. Limited human studies and animal studies show potential harm to the baby. Consult your doctor for risks and benefits before use. If pregnant or planning, consult your physician before taking Jublin-M Capsule

scroll

breastfeeding

Caution should be exercised while breastfeeding and considering the use of Jublin-M Capsule. Limited data indicates potential transfer of the drug to breastmilk which could pose risks to the baby. Consult a doctor before use.


Age above 75(Geriatrics)

Jublin-M Capsule should be used with caution in elderly patients (aged above 75 years) with kidney problems and the elderly in general as it causes dizziness and sleepiness which could increase the occurrence of accidental injury (fall) in them. Consult your doctor before taking it.


Age below 6 months(Pediatrics)

Jublin-M Capsule is not recommended for use in children and adolescents (under 18 years of age). Consult your doctor before taking it.


Consumption warning before consuming Jublin-M Capsule

Before consuming Jublin-M Capsule, it is important to consult your physician, especially if you are pregnant, breastfeeding, or scheduled for surgery. This medication is not suitable for children as its safety and effectiveness have not been established for this age group. It is advised to avoid alcohol consumption while taking Jublin-M Capsule to prevent potential adverse reactions. Additionally, caution should be exercised when using this medication in combination with anti-tumor drugs, antibiotics, chemotherapy, anti-diabetic medications, thyroid hormones, or blood thinners. Be sure to discuss any potential interactions with your healthcare provider to ensure safe and effective use of Jublin-M Capsule.


Disease interactions

When taking Jublin-M Capsule, it is important to inform your physician if you have certain health conditions. These include angioedema, creatine kinase elevations, peripheral edema, malabsorption, and anemia. By disclosing these conditions to your healthcare provider, they can assess the potential interactions between the disease and the medication. This proactive approach helps in ensuring the effectiveness of the treatment and minimizing any risks associated with the use of Mecofol PG capsule.


What if you forgot to take Jublin-M Capsule?

If you forget to take a dose of Jublin-M Capsule, try to take it as soon as you remember. But if it's close to the time for your next dose, it's better to skip the missed one and continue with your usual schedule. Remember not to take a double dose to make up for the missed one.


What happens if you take overdose of Jublin-M Capsule?

If you or someone has taken an excessive amount of Jublin-M Capsule by accident, it is important to seek medical help promptly. An overdose of this medication can lead to various symptoms such as sleepiness, confusion, agitation, restlessness, or fits. Immediate consultation with a doctor is essential to address any potential concerns related to an overdose situation.


Related lab tests

Related Lab Tests for monitoring patients taking Jublin-M Capsule include nerve conduction testing and electromyography. Nerve conduction testing evaluates the speed and strength of electrical signals as they travel along the nerves, helping to detect nerve damage or dysfunction. Electromyography measures the electrical activity in muscles, aiding in the diagnosis of conditions affecting the muscles or nerves controlling the muscles. These tests can provide valuable information on nerve and muscle function, helping healthcare providers assess the effectiveness of treatment with Jublin-M Capsule.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassNEURO CNS
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

199.65

Inclusive of all taxes

Content verified by

chevron-right

Dr. Abdullah Khan

MBBS - General Medicine

Last update on 18-Nov-2024